Berdagang Novavax NVAX

Jual
 Beli

Novavax carta live

5m 15m 30m 1h 4h 1d 1w

Asas Instrumen

Weekly Search
Weekly
Daily
Tarikh Tutup Perubahan Perubahan (%): Buka Tinggi Rendah

Novavax news

2021 Mei 11, 13:20

US pre-market: selling unabated

2021 Mei 06, 08:27

Stocks rally as Fed speakers get back on script, earnings support + Bank of England set to raise forecasts

2021 Feb 28, 07:36

Week Ahead: RBA speaks, US NFPs released & OPEC clash

2020 Mei 26, 08:04

Leg up: stocks make new ground, travel stocks soar

Berita Terkini

Tunjukkan lebih lagi
Noah Lee 2025 Aug 04, 02:20

Trump's Nuclear Rhetoric: Just a Diversion or Real Escalation?

Emma Rose 2025 Aug 04, 01:20

India Defies Trump's Threats, Continues Russian Oil Imports: Energy Security vs. Geopolitics

Sophia Claire 2025 Aug 04, 01:20

Trump's Tariffs on Switzerland: Recession Fears and Potential Deal Adjustments

Bank of England BoE
Tommy Yap 2025 Aug 02, 21:00

Week Ahead: Interest Rate Decisions from BoE in Focus

Forex Indices
Noah Lee 2025 Aug 02, 00:20

Market Review: Trump Tariffs, Fed Rate Hike Expectations, and Mixed Economic Data

Noah Lee 2025 Aug 01, 23:20

Market Review: Trump Tariffs, Fed Policy, Digital Assets, and Key Developments

Ava Grace 2025 Aug 01, 15:20

OPEC+ at a Crossroads: Production Hike and Future Market Challenges

Sophia Claire 2025 Aug 01, 14:20

US Job Growth Slows: Implications for the Federal Reserve

Maklumat

Sebaran nilai

0.05

Spread (%)

0.7645 %

Leveraj

1:10

Faedah semalaman (Beli)

-0.0597 %

Faedah semalaman (Jual)

-0.0292 %

Mata wang

USD

Waktu perdagangan

Pasaran ditutup

Isnin

13:31 - 19:59

Selasa

13:31-19:59

Rabu

13:31-19:59

Khamis

13:31-19:59

Jumaat

13:31-19:59

Analisis dan statistik

Buka

---

Tutup Terdahulu

---

Tinggi/Rendah 52 Minggu

--- – ---

Modal pasaran

1062523200

Saham Tertunggak

161970000

Tarikh Pendapatan (Seterusnya)

2019-05-10

Hasil Div

2019-05-10

Tarikh Selepas Dividen

Kadar dividen tahunan depan

0

Hasil dividen tahunan depan

0

EPS

2.75

Ketahui lebih lanjut mengenai instrumen ini

Novavax Novavax Inc
Novavax, Inc., a biotechnology company, engages in the discovering, developing, and commercializing vaccines to protect against serious infectious diseases in the United States, Europe, and internationally. The company offers vaccine platform that combines a recombinant protein approach, nanoparticle technology, and its patented Matrix-M adjuvant to enhance the immune response. The company is commercializing a COVID-19 vaccine, NVX-CoV2373 under the brand names of Nuvaxovid, Covovax, and Novavax COVID-19 Vaccine, adjuvanted for adult and adolescent populations as a primary series and for both homologous and heterologous booster indications. It also developing R21/Matrix-M adjuvant malaria vaccine. Novavax, Inc. was incorporated in 1987 and is headquartered in Gaithersburg, Maryland.

Instrumen Berkaitan

Aset
Jual
Beli
Perubahan (%):

Berdaganglah Sekarang

Berdaganglah Sekarang

Berdaganglah Sekarang

Berdaganglah Sekarang
Instrumen Berkaitan

latest_education_articles

Tunjukkan lebih lagi
Trustpilot